Attunio Health Expands AI-Powered Precision Psychiatry Platform with Quest Diagnostics and Getlabs
核心洞察
Attunio Health (搜索) selected Quest Diagnostics as its national laboratory backbone and integrated Getlabs (搜索) for at-home blood collection just days after its public launch.
The platform merges AI-driven clinical insights, wearable physiological data, blood biomarker analysis, genetic testing, and behavioral observation into a "Closed-Loop Precision Psychiatry" model.
Diagnostic capabilities help clinicians identify biological contributors to mental health impairment including metabolic dysfunction, inflammation, nutritional deficiencies, and hormonal imbalances.
Just days after publicly launching its AI-powered precision psychiatry platform, Attunio Health (搜索) announced a major expansion of its clinical infrastructure by selecting Quest Diagnostics as its national laboratory backbone and integrating Getlabs (搜索) for at-home blood collection. The announcement, made June 25, 2026 from Atlanta, marks another significant milestone in the company's rapid growth as it builds what it describes as the future of mental healthcare: continuous, objective, data-driven care powered by artificial intelligence, biomarkers, and real-world patient signals.
A Fundamentally Different Model for Psychiatry
Traditional psychiatry has long relied on subjective symptom reporting, episodic visits, and trial-and-error medication management. Attunio is building a fundamentally different model that merges clinical insights provided through artificial intelligence, physiological information collected by wearable devices, blood biomarker analysis, genetic testing, behavioral observation, and medical professional-directed therapy enhancement.
This infrastructure powers what Attunio calls Closed-Loop Precision Psychiatry — a model in which psychiatric treatment is continuously informed by evolving biological and behavioral data rather than limited to occasional appointments.
Quest Diagnostics as National Laboratory Backbone
With Quest Diagnostics serving as Attunio's national laboratory backbone, the platform can support scalable access to advanced diagnostic testing across the United States. These diagnostic capabilities help clinicians identify biological contributors to mental health impairment, including impaired metabolic function, persistent inflammation, lack of essential vitamins and nutrients, disrupted hormonal equilibrium, drug processing and safety indicators, and measures of neurobiological performance.
At-Home Testing Through Getlabs (搜索) Integration
Attunio has also integrated Getlabs (搜索) to enable blood and genetic testing from home, allowing certified mobile phlebotomists to travel directly to patients' homes or workplaces for specimen collection. This approach dramatically reduces friction in diagnostic testing and makes biomarker-driven psychiatric care more accessible to patients nationwide.
Answering Critical Clinical Questions
By combining diagnostic testing with wearable data and AI analysis, Attunio aims to help clinicians answer critical questions that traditional psychiatric visits often cannot address: Is declining focus caused by ADHD (搜索) progression or poor sleep? Is worsening anxiety (搜索) linked to physiological stress or metabolic dysfunction? Is medication underperforming due to biology, genetics, or adherence? Can deterioration be detected before a patient reaches crisis?
Positioning at the Intersection of Psychiatry, Diagnostics, and AI
As interest accelerates around AI in healthcare, digital biomarkers, and precision medicine, Attunio is positioning itself at the intersection of psychiatry, diagnostics, and artificial intelligence. The company believes mental healthcare must evolve beyond reactive care toward a future that is predictive, measurable, and personalized.
This latest infrastructure expansion builds on Attunio's recent launch, which introduced a new model of behavioral healthcare centered on wearable data, biomarker analysis, and AI-powered clinical intelligence designed to improve outcomes for conditions such as ADHD (搜索), anxiety (搜索), depression (搜索), and cognitive burnout.